Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
- 5 April 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 11 (S4), S33-S44
- https://doi.org/10.1038/nm1221
Abstract
Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis annually cause 3 million and 2 million deaths, respectively. Last year, 600,000 individuals, doubly infected with HIV and M. tuberculosis, died. Since World War I, approximately 150 million people have succumbed to these two infections—more total deaths than in all wars in the last 2,000 years. Although the perceived threats of new infections such as SARS, new variant Creutzfeldt-Jakob disease and anthrax are real, these outbreaks have caused less than 1,000 deaths globally, a death toll AIDS and tuberculosis exact every 2 h. In 2003, 40 million people were infected with HIV, 2 billion with M. tuberculosis, and 15 million with both. Last year, 5 million and 50 million were newly infected with HIV or M. tuberculosis, respectively, with 2 million new double infections. Better control measures are urgently needed.Keywords
This publication has 117 references indexed in Scilit:
- Iron and microbial infectionNature Reviews Microbiology, 2004
- Repeated Low-Dose Mucosal Simian Immunodeficiency Virus SIVmac239 Challenge Results in the Same Viral and Immunological Kinetics as High-Dose Challenge: a Model for the Evaluation of Vaccine Efficacy in Nonhuman PrimatesJournal of Virology, 2004
- Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosisNature Immunology, 2003
- Cross-priming of CD8+ T cells stimulated by virus-induced type I interferonNature Immunology, 2003
- Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosisNature Medicine, 2003
- Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population LevelScience, 2002
- Genetics of susceptibitlity to human infectious diseaseNature Reviews Genetics, 2001
- Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative TreatmentNew England Journal of Medicine, 1999
- ESCAPE OF HUMAN IMMUNODEFICIENCY VIRUS FROM IMMUNE CONTROLAnnual Review of Immunology, 1997
- Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccinesNature, 1991